Hansa Biopharma — Major Shareholding Notification 2018

Nov 19, 2018

Issuer Hansa Biopharma AB

Holder

NEXTTOBE AB

Instrument

Instrument	Ordinary shares SE0002148817
Before the transaction
Shares	6,643,761
Voting rights	6,643,761
Transaction
Reason for major shareholding notification Other
Date	16/11/2018
Limit for number of shares	15 %
Limit for number of votes	15 %
After the transaction
Quantity
Shares	5,755,379
Directly held voting rights	5,755,379
Indirectly held voting rights	0
Percentage
Directly held shares	14.14735 %
Directly held voting rights	14.37692 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		14.37692 %	5,755,379
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total		14.37692 %	5,755,379
Group total holdings
Voting rights	5,755,379

Percentage of voting rights 14.37692

Notes (other relevant informations according to law)

Transaktionen avser en försäljning av aktier för Nexttobe AB samt en riktad nyemission i Hansa Medical. Flaggningen har baserats på det totala antalet aktier som Hansa Medical har efter den riktade emissionen (40 681 654 aktier och 40 032 066 röster).

Published

19/11/2018 10:23

Contact

Name Erika Kjellberg Eriksson

Phone 018-507444 Email info@next2be.com

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25